Company Overview
Select Pharma Laboratories Ltd. is listed at the official companies registry as Active Private Limited Company. The company was incorporated on Friday 20 November 2009, so this is a well established company. Select Pharma Laboratories Ltd. has been in business for 16 years and 4 months. The accounts status is audit exemption subsidiary and the accounts are next due on Wednesday 30 September 2026.
Registered Address

3Rd Floor 2 Semple Street, Edinburgh, EH3 8BL
Credit Reports Available

These credit rating reports are available now:


Credit Analysts Report
Get Report >>

Standard Credit Report
Get Report >>

Basic Credit Report
Get Report >>

24/7 credit rating data feed - no UK company credit reports are updated faster

Companies House Data
Company NameSELECT PHARMA LABORATORIES LTD.
Company NumberSC368899
Registered Office Address3rd Floor 2 Semple Street
 EH3 8BL
Company CategoryPrivate Limited Company
Company StatusActive
Country of OriginUnited Kingdom
Incorporation Date20/11/2009
Accounting Reference Date Day30
Accounting Reference Date Month12
Accounts Next Due Date30/09/2026
Accounts Last Made Up Date31/12/2024
Accounts Account CategoryAUDIT EXEMPTION SUBSIDIARY
Returns Next Due Date18/12/2016
Returns Last Made Up Date20/11/2015
Directors & Members
Show Resigned
Amanda Barlow - Director
(British, 53 years old, born August 1973)
Appointed 27 September 2023
 Active
Jay Lecoque - Director
(American, 64 years old, born November 1962)
Appointed 27 April 2017
 Active
Secretaries
Show Resigned
Other Company Directorships
Amanda Barlow
CAMBRIDGE CLINICAL LABORATORIES LTD
CRYOBANK GUARANTOR LIMITED
DARLEY HOLDINGS LIMITED
DARLEY LIMITED
FAIRFIELD IMAGING LIMITED
FAIRFIELD TELEPATHOLOGY LIMITED
GENESERVICE LIMITED
KINETIC IMAGING LIMITED
LDPATH LIMITED
PLUSONE PROPERTIES LIMITED
PROJECT MOUSE NEWCO LIMITED
SOURCE BIOSCIENCE (CRYOBANK) LIMITED
SOURCE BIOSCIENCE (ORCHARD PLACE) LIMITED
SOURCE BIOSCIENCE LIMITED
SOURCE BIOSCIENCE SCOTLAND LIMITED
SOURCE BIOSCIENCE UK LIMITED
SOURCE GENOMICS LIMITED
SOURCEBIO INTERNATIONAL LIMITED
Jay Lecoque
AUTOGEN BIOCLEAR UK LIMITED
BIOQUELL LIMITED
CELSIS GROUP LIMITED
CELSIS INTERNATIONAL LIMITED
CELSIS LIMITED
CRYOBANK GUARANTOR LIMITED
FAIRFIELD IMAGING LIMITED
FAIRFIELD TELEPATHOLOGY LIMITED
GENESERVICE LIMITED
HISTOLOGICAL SOLUTIONS LTD
INVERCLYDE BIOLOGICALS LIMITED
KINETIC IMAGING LIMITED
MEDICAL SOLUTIONS (LEEDS) LIMITED
MEDICAL SOLUTIONS LIMITED
PATHLORE LTD
QUINODERM LIMITED
RAPID LITIGATION MANAGEMENT LTD
SELECT STORAGE SOLUTIONS (SCOTLAND) LTD.
SOURCE BIOSCIENCE (CRYOBANK) LIMITED
SOURCE BIOSCIENCE (DIRECTORS) LIMITED
SOURCE BIOSCIENCE (HEALTHCARE) LIMITED
SOURCE BIOSCIENCE (ORCHARD PLACE) LIMITED
SOURCE BIOSCIENCE (STORAGE) LIMITED
SOURCE BIOSCIENCE LIMITED
SOURCE BIOSCIENCE SCOTLAND LIMITED
SOURCE BIOSCIENCE UK LIMITED
SOURCEBIO INTERNATIONAL LIMITED
VINDON LIMITED
Balance Sheet Unlock full report
Accounts Date 31-Dec-2024 31-Mar-2012 31-Mar-2011
Balance Sheet
Fixed Assets 177,917 177,917 114,691
Current Assets 801,606 801,606 372,441
Creditors Due Within One Year 359,497 359,497 267,293
Working Cap 442,109 442,109 105,148
Total Assets Less Current Liabilities 620,026 620,026 219,839
Long-term Liabilities 62,866 62,866 32,836
Net Assets 557,160 557,160 187,003
Share Capital & Reserves
Share Cap 40,000 40,000 980
Profit & Loss Reserves 517,160 517,160 186,023
Other Reserves 0 0 0
Shareholders Funds 557,160 557,160 187,003
Common Size Financial Analysis Unlock full report
Accounts Date 31-Dec-2024 31-Mar-2012 31-Mar-2011
Tangible Fixed Assets - - -
Fixed Assets 18.2% 18.2% 23.5%
Stocks Inventory 0.1% 0.1% 0.2%
Debtors 19.3% 19.3% 25.5%
Cash Bank In Hand 62.4% 62.4% 50.8%
Current Assets 81.8% 81.8% 76.5%
Creditors Due Within One Year 36.7% 36.7% 54.9%
Net Current Assets Liabilities 45.1% 45.1% 21.6%
Creditors Due After One Year 4.0% 4.0% 2.9%
Accruals Deferred Income - - -
Provisions For Liabilities Charges - - -
Net Assets Liabilities Including Pension Asset Liability 56.9% 56.9% 38.4%
Called Up Share Capital 4.1% 4.1% 0.2%
Share Capital Allotted Called Up Paid 4.1% 4.1% 0.2%
Profit Loss Account Reserve 52.8% 52.8% 38.2%
Shareholder Funds 56.9% 56.9% 38.4%
Capital Employed - - -
Total Assets Less Current Liabilities 63.3% 63.3% 45.1%
Financial Ratio Analysis Unlock full report
Accounts Date 31-Dec-2024 31-Mar-2012 31-Mar-2011
Liquidity Ratio 2.2 2.2 1.4
Solvency Ratio 2.3 2.3 1.6
Reserves to Assets 0.5 0.5 0.4
Secured Creditors Unlock full report
Mortgages Charges 3
Mortgages Outstanding 0
Mortgages Part Satisfied 0
Mortgages Satisfied 3
Assets and Debt Analysis Unlock full report
Accounts Date 31-Dec-2024 31-Mar-2012 31-Mar-2011
Assets 979,523 979,523 487,132
Debt 422,363 422,363 300,129
Net Assets/Debt 557,160 557,160 187,003

The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.

The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves appeared positive. We would normally view a company positively for this. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.

Unlock full report  The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves appeared positive. We would normally view a company positively for this. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.   The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves appeared positive. We would normally view a company positively for this. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.

This review of public record balance sheet and company status information is presented under the terms of Open Government Licence and is for informational purposes only, is general in nature, and is not intended as an opinion or advice for any specific circumstances. The commentary and the colour band score is not a credit rating or credit risk assessment.

This review does not constitute a full credit rating or credit risk assessment based on the full analysis and credit score algorithms used in our credit reports. A full credit report may also provide information relating to trade payment history and county court or court judgments if any.

Public Record Information Unlock full report
Exact Court Judgements
Period of Months Last 12m 13-24m 25-36m 37-48m 49-60m 61-72m
Number of Exact CCJS X Y Y X X Y
Value of Exact CCJS YXY YK S S X KX
Supplier Credit Limits Unlock full report
Date Sector Notified Amount Terms
XK-SXY XKXYXK SXSKXYXK £X,000 XS XYSKS
SK-SYY SKXYXKYKKY KSXX KKXXYXS £YY,000 YS XYSKS SK YXXSXS
YK-SXY XKXYXYYK SXSXYXK £SX,000 XS XYSKS
Payment Records Unlock full report
Payment Records from it's suppliers' company ledger show how a company is paying its suppliers

Payment Analysis

Total Invoices Paid Before
30 days due		 Paid After
30 days due		 Owing Before
30 days due		 Owing after
30 days due
XYX SX K YX X
Company Valuation Analysis Unlock full report

Going Concern Valuation

The going concern valuations value the company on the basis that it continues to trade without the threat of liquidation for the foreseeable future. These valuations are primarily profit and cashflow based.

Valuations Valuation Measures
Estimated High Value £XSI,000 Retained Profit £YX,000
Estimated Mid Value £YY,000 EBIT £SY,000
Estimated Low Value £X,000 EBITDA £SSX,000

Liquidation Valuation

The liquidaton valuation values the company as if it were to cease trading and assets were subject to rapid disposal to cover liabilities. This valuation is primarily asset based.

Valuations Valuation Measures
Estimated High Value £XY,000 Total Assets £XIX,000
Estimated Mid Value £Y,000 Net Assets £YX,000
Estimated Low Value £S,000 Tangible Equity £SX,000

The above valuations are based on our own algorithms and take no account of many factors that can influence actual valuations realized and should not therefore be assumed to be accurate.
Credit Status Checklist Unlock full report
Business Growth Please purchase a report to see true comments
EBITDA Purchase a report to see true comments
Dividends Please purchase a report to see true comments about this company
Retained Profits Retained Profits for this company
Debt Interest Debt Interest for this company
Cash Flow Cash Flow for this company
CCJs CCJs for this company
Age of Company Age of Company for this company
Solvency Solvency for this company
Secured Creditors Secured Creditors for this company
Ownership Ownership for this company


First Report Score: (0-10) X
Financial Status Guide:
10 Very Strong
9 Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical

Risk Score Trend

Risk Rating Unlock full report

This is the credit risk assessment used by one of the top UK credit reference agencies.

Risk Score (1-100) X
Risk Band Description XXMXMXMX SISX
Risk Assessment Meeting of Creditors
Credit Rating XSKX
Altman Z Score Credit Risk Rating Unlock full report

There have been many bankruptcy predictors developed, however none has been so thoroughly tested and broadly accepted as the Altman Z-Score.

Z Score X
Risk Band XY
Risk Band Description The Z Score is not used for small companies where full accounts are not filed because profit and loss account items are required to calculate the score.

Z Score Bands

1 Low Risk 3.00 and above
2 Caution 2.63 - 2.99
3 Risk of Failure within 2 years 1.24 - 2.62
4 High Probability Failure Below 1.24
Other Business around EH3 8BL
COLERIDGE (NO.1) LIMITED
1st Floor Exchange Place 3, 3 Semple Street, Edinburgh, EH3 8BL
WARDMILL LIMITED
2nd Floor Excel House, Semple Street, Edinburgh, EH3 8BL
D.U.K.E. PROPERTIES (UK) LIMITED
1st Floor Exchange Place 3, 3 Semple Street, Edinburgh, EH3 8BL
MORGAN BLAIR LIMITED
Begbies Traynor (Central) Llp 2nd Floor Excel House, Semple Street, Edinburgh, EH3 8BL
PROTRIALS GLOBAL LIMITED
4th Floor, Exchange Place 3, Semple Street, Edinburgh, EH3 8BL
CHOCO LATTE (EDINBURGH) LTD
Second Floor Excel House, Semple Street, Edinburgh, EH3 8BL
FAIR-PRICE KITCHENS & BATHROOMS LTD.
Second Floor Excel House, Semple Street, Edinburgh, EH3 8BL
I M U TRANSGLOBAL LIMITED
Begbies Traynor (Central) Llp 2nd Floor Excel House, Semple Street, Edinburgh, EH3 8BL
BOWIE ENGINEERING CONSULTANCY LTD
Begbies Traynor (Central) Llp 2nd Floor Excel House, Semple Street, Edinburgh, EH3 8BL
SARAH ANNE WILLIAMS LIMITED
Begbies Traynor (Central) Llp 2nd Floor Excel House, Semple Street, Edinburgh, EH3 8BL
Document Filings
Confirmation statement made on 3 November 2025 with updates
Consolidated accounts of parent company for subsidiary company period ending 31/12/24
Notice of agreement to exemption from audit of accounts for period ending 31/12/24
Audit exemption statement of guarantee by parent company for period ending 31/12/24
Confirmation statement made on 20 November 2024 with updates
Confirmation statement made on 20 November 2023 with updates
Termination of appointment of Anthony James Ratcliffe as a director on 27 September 2023
Appointment of Mrs Amanda Louise Barlow as a director on 27 September 2023
Confirmation statement made on 20 November 2022 with updates
Termination of appointment of David Michael Kirkham as a director on 26 September 2022
Registered office address changed from First Floor, Quay 2 139 Fountainbridge Edinburgh EH3 9QG Scotland to 3rd Floor 2 Semple Street Edinburgh EH3 8BL on 11 April 2022
Confirmation statement made on 20 November 2021 with updates
Appointment of Mr Anthony James Ratcliffe as a director on 28 June 2021
Appointment of Mr David Michael Kirkham as a director on 15 June 2021
Termination of appointment of Russell Steven Wheatcroft as a director on 15 June 2021
Satisfaction of charge SC3688990002 in full
Satisfaction of charge SC3688990003 in full
Change of details for Source Bioscience Limited as a person with significant control on 21 January 2021
Confirmation statement made on 20 November 2020 with updates
Terms and Conditions Cancellations Contact Us

In using this service you agree to the Terms and Conditions

© 2026 Check Free